Literature DB >> 1444649

The effect of pancreatic polypeptide on glucose disposal after surgical alterations of the pancreas.

H M Prillaman1, S B Cox, A E Freedlender, G E Cornett, H A Jones, T L Flanagan, R E Chance, J A Hoffmann, D K Andersen, D Elahi.   

Abstract

Surgical alterations of the pancreas result in anatomic changes that can affect postoperative glucose metabolism. Pancreas transplantation results in reduction of beta-cell mass, systemic release of insulin, and denervation. The authors hypothesized that such alterations affect peripheral glucose disposal to induce an "insensitivity" to endogenously (systemically) released insulin. Additionally, they hypothesized that surgically induced deficiency of the postprandial hormone, pancreatic polypeptide, might contribute to altered glucose disposal. The authors studied two surgical models in dogs known to be devoid of pancreatic polypeptide--70% proximal pancreatectomy (PPx) and PPx plus distal pancreas autotransplantation (PAT/B). Oral glucose challenge and euglycemic hyperinsulinemic clamp studies were performed before and after a 16-day "pulsed" infusion of pancreatic polypeptide. Both surgical procedures resulted in elevations in the integrated glucose response after oral glucose, which was not affected by pancreatic polypeptide infusion. Euglycemic clamp studies showed decreased hepatic glucose output (Ra) and overall glucose disposal (Rd) in the fasted state for both surgical groups. The transplant animals demonstrated significant decreases in Rd during the hyperinsulinemic challenge (3.2 +/- 0.01 versus 5.7 +/- 0.01 mg/kg/minute at 60 to 120 minutes for PAT/B versus control). After 16 days of pancreatic polypeptide infusion, however, basal Ra, as well as basal and 60- to 120-minute Rd values, were returned to control values in the transplant group. The authors conclude that pancreas transplantation results in altered glucose disposal, possibly due to an altered effectiveness of systemically released insulin. They conclude that pancreatic polypeptide is an important modulator of peripheral insulin action. Therefore, the role of pancreatic polypeptide must be taken into account when evaluating postoperative glucose metabolism in canine models of pancreas transplantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444649      PMCID: PMC1242676          DOI: 10.1097/00000658-199211000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.

Authors:  J L Leahy; S Bonner-Weir; G C Weir
Journal:  Diabetes       Date:  1984-07       Impact factor: 9.461

2.  Human pancreatic polypeptide inhibits insulin release in the rat.

Authors:  W A Murphy; J L Fries; C A Meyers; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1981-07-16       Impact factor: 3.575

3.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

4.  Elevated levels of pancreatic polypeptide in obese-hyperglycemic mice.

Authors:  R L Gingerich; D J Gersell; M H Greider; E H Finke; P E Lacy
Journal:  Metabolism       Date:  1978-10       Impact factor: 8.694

5.  Underestimation of hepatic glucose production by radioactive and stable tracers.

Authors:  G M Argoud; D S Schade; R P Eaton
Journal:  Am J Physiol       Date:  1987-05

6.  Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide.

Authors:  Y S Sun; F C Brunicardi; P Druck; S Walfisch; S A Berlin; R E Chance; R L Gingerich; D Elahi; D K Andersen
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

7.  Plasma responses of pancreatic polypeptide, glucagon and insulin in normal and alloxan diabetic dogs, and their regional levels in the pancreas.

Authors:  Y Tasaka; S Inoue; K Marumo; Y Hirata
Journal:  Acta Endocrinol (Copenh)       Date:  1984-02

8.  Peripheral insulin release after pancreatic resection: the effect of decreased beta-cell mass with systemic or portal drainage.

Authors:  D A Krusch; K B Brown; P C Calhoun; A E Freedlender; D L Kaiser; D Elahi; J B Hanks
Journal:  Endocrinology       Date:  1988-07       Impact factor: 4.736

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Insulin-sparing effects of pancreatic polypeptide in congenitally obese rodents.

Authors:  T W Gettys; R Garcia; K Savage; D C Whitcomb; S Kanayama; I L Taylor
Journal:  Pancreas       Date:  1991-01       Impact factor: 3.327

View more
  1 in total

1.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.